P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1

Benzer Materyaller

• The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
  Yazar:: Xiaoxia Wu, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-09-01)
• Comparison of allogeneic hematopoietic stem cell transplantation and TKI combined with chemotherapy for adult philadelphia chromosome positive acute lymphoblastic leukemia: a systematic review and meta‐analysis
  Yazar:: Qiang Zeng, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-12-01)
• Philadelphia chromosome-positive acute lymphoblastic leukemia in childhood
  Yazar:: Hong Hoe Koo
  Baskı/Yayın Bilgisi: (2011-03-01)
• Clinical efficacy of chemotherapy followed by allogeneic hematopoietic stem cell transplantation with continuous tyrosine kinase inhibitor administration in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: a retrospective analysis
  Yazar:: Xinnan Chen, ve diğerleri
  Baskı/Yayın Bilgisi: (2026-05-01)
• Reduced-intensity chemotherapy with tyrosine kinase inhibitor followed by allogeneic transplantation is effective in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
  Yazar:: Jung Min Lee, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-01-01)